FARXIGA

FARXIGA is a prescription medicine used to:

• improve blood sugar control along with diet and exercise in adults with type 2 diabetes

• reduce the risk of hospitalization for heart failure in adults with type 2 diabetes and known cardiovascular disease or multiple cardiovascular risk factors

• reduce the risk of cardiovascular death and hospitalization for heart failure in adults with symptomatic heart failure (when the heart is weak and cannot pump enough blood to the rest of your body)

• reduce the risk of further worsening of your kidney disease, end-stage kidney disease, death due to cardiovascular disease, and hospitalization for heart failure in adults with chronic kidney disease

FARXIGA is not for people with type 1 diabetes. FARXIGA may increase the risk of diabetic ketoacidosis (increased ketones in your blood or urine) in people with type 1 diabetes.

FARXIGA is not for use to improve blood sugar (glucose) control in adults with type 2 diabetes who have moderate to severe kidney problems, because it may not work.

FARXIGA is not for people with certain genetic forms of polycystic kidney disease, or who are taking or have recently received immunosuppressive therapy to treat kidney disease. FARXIGA is not expected to work if you have these conditions.